Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China
· Delayed Price · Currency is CNY 17.47
-0.78 (-4.27%)
Apr 29, 2026, 3:00 PM CST
SHA:603896 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 640.18 | 677.92 | 770.34 | 817.67 | 759.99 | Upgrade
|
| Other Revenue | - | 13.76 | 14.01 | 11.4 | 7.15 | Upgrade
|
| Revenue | 640.18 | 691.68 | 784.35 | 829.07 | 767.14 | Upgrade
|
| Revenue Growth (YoY) | -7.45% | -11.81% | -5.39% | 8.07% | 20.61% | Upgrade
|
| Cost of Revenue | 136.55 | 133.35 | 135.53 | 129.21 | 126.37 | Upgrade
|
| Gross Profit | 503.63 | 558.34 | 648.82 | 699.86 | 640.76 | Upgrade
|
| Selling, General & Admin | 363.74 | 390.75 | 403.79 | 405.17 | 397.19 | Upgrade
|
| Research & Development | 51.64 | 48.41 | 49.68 | 47.82 | 50.82 | Upgrade
|
| Other Operating Expenses | -35.64 | -2.21 | -4.52 | 6.84 | 7.67 | Upgrade
|
| Operating Expenses | 379.73 | 436.85 | 447.73 | 461.41 | 456.47 | Upgrade
|
| Operating Income | 123.9 | 121.49 | 201.09 | 238.45 | 184.3 | Upgrade
|
| Interest Expense | - | -14.78 | -24.7 | -13.03 | -10.17 | Upgrade
|
| Interest & Investment Income | 3.76 | 36.84 | 51.77 | 29.99 | 31 | Upgrade
|
| Other Non Operating Income (Expenses) | -33.71 | -0.47 | -0.43 | -0.68 | -0.56 | Upgrade
|
| EBT Excluding Unusual Items | 93.94 | 143.08 | 227.72 | 254.73 | 204.57 | Upgrade
|
| Gain (Loss) on Sale of Investments | 7.78 | 4.63 | 0.27 | -1.26 | -12.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.41 | 8.81 | 0.17 | 0.07 | 0.03 | Upgrade
|
| Asset Writedown | - | -0.02 | -0.03 | -0.06 | -0 | Upgrade
|
| Other Unusual Items | - | 18.22 | 26.77 | 24.48 | 8.79 | Upgrade
|
| Pretax Income | 102.14 | 174.73 | 254.91 | 277.97 | 201.06 | Upgrade
|
| Income Tax Expense | 84.02 | 0.01 | 0.43 | 0.45 | 0.75 | Upgrade
|
| Earnings From Continuing Operations | 18.12 | 174.71 | 254.48 | 277.51 | 200.31 | Upgrade
|
| Minority Interest in Earnings | 0.05 | - | - | 0.27 | 0.52 | Upgrade
|
| Net Income | 18.17 | 174.71 | 254.48 | 277.78 | 200.83 | Upgrade
|
| Net Income to Common | 18.17 | 174.71 | 254.48 | 277.78 | 200.83 | Upgrade
|
| Net Income Growth | -89.60% | -31.34% | -8.39% | 38.32% | 32.37% | Upgrade
|
| Shares Outstanding (Basic) | 202 | 199 | 196 | 194 | 191 | Upgrade
|
| Shares Outstanding (Diluted) | 202 | 199 | 196 | 194 | 191 | Upgrade
|
| Shares Change (YoY) | 1.71% | 1.42% | 0.77% | 1.56% | 3.77% | Upgrade
|
| EPS (Basic) | 0.09 | 0.88 | 1.30 | 1.43 | 1.05 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.88 | 1.30 | 1.43 | 1.05 | Upgrade
|
| EPS Growth | -89.77% | -32.31% | -9.09% | 36.19% | 27.57% | Upgrade
|
| Free Cash Flow | -45.15 | -293.62 | -99.48 | 158.68 | 135.07 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -1.48 | -0.51 | 0.82 | 0.71 | Upgrade
|
| Dividend Per Share | - | 0.270 | 0.390 | 0.440 | 0.311 | Upgrade
|
| Dividend Growth | - | -30.77% | -11.36% | 41.25% | 29.79% | Upgrade
|
| Gross Margin | 78.67% | 80.72% | 82.72% | 84.41% | 83.53% | Upgrade
|
| Operating Margin | 19.35% | 17.56% | 25.64% | 28.76% | 24.02% | Upgrade
|
| Profit Margin | 2.84% | 25.26% | 32.45% | 33.51% | 26.18% | Upgrade
|
| Free Cash Flow Margin | -7.05% | -42.45% | -12.68% | 19.14% | 17.61% | Upgrade
|
| EBITDA | 201.92 | 185.96 | 267.62 | 295.78 | 233.47 | Upgrade
|
| EBITDA Margin | 31.54% | 26.88% | 34.12% | 35.68% | 30.43% | Upgrade
|
| D&A For EBITDA | 78.03 | 64.47 | 66.53 | 57.33 | 49.17 | Upgrade
|
| EBIT | 123.9 | 121.49 | 201.09 | 238.45 | 184.3 | Upgrade
|
| EBIT Margin | 19.35% | 17.56% | 25.64% | 28.76% | 24.02% | Upgrade
|
| Effective Tax Rate | 82.26% | 0.01% | 0.17% | 0.16% | 0.37% | Upgrade
|
| Revenue as Reported | - | 691.68 | 784.35 | 829.07 | 767.14 | Upgrade
|
| Advertising Expenses | - | 190.46 | 201.21 | 201.3 | 198.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.